A phase II trial shows that the risk of cancer recurrence as reflected by circulating tumour DNA can guide a risk-adaptive treatment strategy that improves participants’ survival compared with the current standard of care. Our biological insights can be translated into clinical decision-making — challenging the conventional fixed-course, therapeutic approach.
Provides suggestions for your topic clusters and related subjects，更多细节参见有道翻译官网
，详情可参考谷歌
Publication date: 10 March 2026，更多细节参见移动版官网
It's no secret that stunt performers often take on the more dangerous moments where a lead actor could get hurt.